Marshall Wace’s Sanara MedTech SMTI Stock Holding History

Marshall Wace’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Sell	49,457 -26,825	-35%	-$555K	﹤0.01%	2123
2026 Q1	$1.31M	Buy	76,282 +27,671	+57%	+$569K	﹤0.01%	2003
2025 Q4	$1.14M	Sell	48,611 -17,462	-26%	-$451K	﹤0.01%	1862
2025 Q3	$2.1M	Sell	66,073 -5,438	-8%	-$164K	﹤0.01%	1587
2025 Q2	$2.03M	Buy	71,511 +42,237	+144%	+$1.27M	﹤0.01%	1559
2025 Q1	$904K	Sell	29,274 -1,011	-3%	-$34.3K	﹤0.01%	1830
2024 Q4	$1.01M	Buy	+30,285	New	+$1.03M	﹤0.01%	1736
2023 Q3	–	Sell	-5,832	Closed	-$234K	–	2643
2023 Q2	$234K	Buy	+5,832	New	+$239K	﹤0.01%	2208

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Marshall Wace's SMTI Position: Q2 2026 in Review

Marshall Wace reduced its Sanara MedTech (SMTI) stake by 35% in Q2 2026, selling an estimated $555K and leaving 49,457 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Marshall Wace first reported a position in SMTI in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.1M in Q3 2025. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Marshall Wace held 49,457 shares of Sanara MedTech worth $1.17M as of Q2 2026.
Marshall Wace sold 26,825 Sanara MedTech shares in Q2 2026, an estimated $555K.
Sanara MedTech made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2123 holding.
Marshall Wace first reported a position in Sanara MedTech in Q2 2023 and has held it in 8 quarters since.
Marshall Wace's Sanara MedTech position peaked at $2.1M in Q3 2025.
75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.